Chromatin remodeling ATPase BRG1 and PTEN are synthetic lethal in prostate cancer
Yufeng Ding(Renji Hospital), Jun Qin(Army Medical University), Xuege Wang(Shanghai Institute of Nutrition and Health), Huairui Yuan(Center for Excellence in Molecular Cell Science), Shan Kan(Shanghai Institutes for Biological Sciences), Tong Qiu(Sichuan University), Ni Li(Fudan University), Dong Gao(Shenzhen Bay Laboratory), Chao Peng(Hunan University of Arts and Science), Qiang Pan‐Hammarström(Karolinska Institutet), Qilong Chen(Tongji University), Qintong Li(Sichuan University), Ying Han(Beijing University of Chemical Technology), Wei Xue(National Sun Yat-sen University), Ping Wu(Key Laboratory of Guangdong Province), Baijun Dong(Shanghai Jiao Tong University), Han-Wen Chang(Shanghai Institute of Nutrition and Health), Wangxin Guo(Center for Excellence in Molecular Cell Science), Hui Wei(Qilu Hospital of Shandong University)
Cited by 92
Related Papers
Changing profiles of cancer burden worldwide and in China: a secondary analysis of the global cancer statistics 2020
|Chinese Medical Journal|2021|3k
Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathway
|Nature|2017|2k
Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: Variation by geographical region, histological type and year of publication
|International Journal of Cancer|2010|1.1k
Human papillomavirus types in 115,789 HPV‐positive women: A meta‐analysis from cervical infection to cancer
|International Journal of Cancer|2012|957